ContextVision reports Q3 operating margin of 39%

Operations during Q3 generated an operating margin of 39% and a very strong cash flow of 8.2 MSEK. Sales for the quarter (16.6) are lower than the same period previous year (23.4). The main reason for this is, as was stated last year, that sales were extraordinary high due to several new large agreements in the USA during Q3 2007. Several new contracts have been signed during the period, such as a Computer Tomography product agreement with a leading OEM and several agreements with leading X-ray Manufacturers across the Globe in USA, China, Israel and South America.

Repurchase of own shares will commence during Q4.

Thursday October 23rd at 15.00 hrs at Felix Konferansesenter (Bryggetorget 3, Oslo) CEO Jan Erik Hedborg will present the Q3 2008 results.

The presentation will also be available as webcast – please follow link

For more information about ContextVision please visit

About Us

ContextVision is the leading independent developer in medical imaging enhancement, analysis and processing technologies, serving leading OEMs and distributors for more than 25 years. ContextVision’s embedded imaging software is relied upon daily by thousands of users around the globe. ContextVision’s patented GOP algorithm allows unprecedented image quality to be achieved by simultaneously enhancing fine structure while reducing noise and speckle across MRI, X-Ray, Ultrasound, CT, and IR. ContextVision’s technology enables the company’s customers to provide superior digital imaging quality to hospitals and clinicians. Such solutions promise more rapid and accurate diagnoses, reduced operator eye fatigue, and ultimately, a greater return-on-investment for medical imaging users. For more information, please visit

Documents & Links